These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31375913)

  • 1. Pharmacokinetics in children with chronic kidney disease.
    Schijvens AM; de Wildt SN; Schreuder MF
    Pediatr Nephrol; 2020 Jul; 35(7):1153-1172. PubMed ID: 31375913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease.
    Malik PRV; Yeung CHT; Ismaeil S; Advani U; Djie S; Edginton AN
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S52-S62. PubMed ID: 33205424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.
    Nolin TD
    Semin Dial; 2015; 28(4):325-9. PubMed ID: 25855244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients.
    Sayama H; Takubo H; Komura H; Kogayu M; Iwaki M
    AAPS J; 2014 Sep; 16(5):1018-28. PubMed ID: 24912798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation.
    Kim DJ; Lee DH; Ahn S; Jung J; Kiem S; Kim SW; Shin JG
    J Clin Pharm Ther; 2019 Oct; 44(5):750-759. PubMed ID: 31228353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.
    Tortorici MA; Cutler DL; Hazra A; Nolin TD; Rowland-Yeo K; Venkatakrishnan K
    J Clin Pharmacol; 2015 Mar; 55(3):241-50. PubMed ID: 25501531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption.
    Huang W; Isoherranen N
    CPT Pharmacometrics Syst Pharmacol; 2020 Oct; 9(10):571-583. PubMed ID: 32977369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters.
    Hsueh CH; Hsu V; Zhao P; Zhang L; Giacomini KM; Huang SM
    Clin Pharmacol Ther; 2018 Mar; 103(3):485-492. PubMed ID: 28738449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease.
    Albrecht D; Turakhia MP; Ries D; Marbury T; Smith W; Dillon D; Milner PG; Midei MG
    Thromb Haemost; 2017 Nov; 117(11):2026-2033. PubMed ID: 28933798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chronic Kidney Disease on Hepatic Clearance of Drugs in Rats.
    Tokunaga A; Miyamoto H; Fumoto S; Nishida K
    Biol Pharm Bull; 2020; 43(9):1324-1330. PubMed ID: 32879206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
    Verbeeck RK; Musuamba FT
    Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ; Urquhart BL
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Assessment of the Effect of Chronic Kidney Disease on the Nonrenal Clearance of 10 Drugs After Intravenous Administration.
    Hinderling PH; Yu Y
    Clin Pharmacol Drug Dev; 2019 Feb; 8(2):138-151. PubMed ID: 30589517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
    Farag A; Garg AX; Li L; Jain AK
    Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug pharmacokinetics in renal failure: What's new?].
    Naud J; Dumayne C; Nolin TD; Leblond FA; Pichette V
    Nephrol Ther; 2015 Jun; 11(3):144-51. PubMed ID: 25861715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation.
    Fernandez-Prado R; Castillo-Rodriguez E; Velez-Arribas FJ; Gracia-Iguacel C; Ortiz A
    Am J Med; 2016 Dec; 129(12):1259-1263. PubMed ID: 27612441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cystatin C and serum creatinine-based glomerular filtration rate equations in predicting vancomycin clearance: A population pharmacokinetics analysis in elderly Chinese patients.
    Ling J; Yang X; Dong L; Jiang Y; Zou S; Hu N
    Biopharm Drug Dispos; 2024 Feb; 45(1):58-68. PubMed ID: 38319316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: pharmacological considerations for the dentist.
    Brockmann W; Badr M
    J Am Dent Assoc; 2010 Nov; 141(11):1330-9. PubMed ID: 21037190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication treatment complexity and adherence in children with CKD.
    Blydt-Hansen TD; Pierce CB; Cai Y; Samsonov D; Massengill S; Moxey-Mims M; Warady BA; Furth SL
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):247-54. PubMed ID: 24262500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.